Literature DB >> 21221400

Prostate Cancer: New serum tumor marker for monitoring patients.

M McCormack.   

Abstract

As the incidence of prostatic cancer rises, family physicians can expect to diagnose and treat increasing numbers of patients with this disease. Recent research has uncovered a new serum tumor marker (prostate-specific antigen), which is useful in patient monitoring and which eventually could be used in screening. A current review of available serum tumor markers is presented.

Entities:  

Year:  1992        PMID： 21221400      PMCID： PMC2146154     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  10 in total

Review 1.  Staging evaluation and follow-up of patients with advanced prostatic cancer.

Authors:  Z Wajsman; I W Klimberg
Journal:  Semin Urol       Date:  1988-11

2.  Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.

Authors:  C J Ercole; P H Lange; M Mathisen; R K Chiou; P K Reddy; R L Vessella
Journal:  J Urol       Date:  1987-11       Impact factor: 7.450

3.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  Cancer statistics, 1989.

Authors:  E Silverberg; J A Lubera
Journal:  CA Cancer J Clin       Date:  1989 Jan-Feb       Impact factor: 508.702

5.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.

Authors:  T A Stamey; J N Kabalin; M Ferrari
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

Review 6.  Prostatic acid phosphatase: its current clinical status.

Authors:  J E Heller
Journal:  J Urol       Date:  1987-06       Impact factor: 7.450

7.  Epidemiology of cancer of the prostate in Canada: 1950-1984.

Authors:  A Ayiomamitis
Journal:  Br J Urol       Date:  1987-08

Review 8.  Early detection of prostate cancer.

Authors:  P T Scardino
Journal:  Urol Clin North Am       Date:  1989-11       Impact factor: 2.241

9.  Prostate-specific antigen for staging prior to surgery and for early detection of recurrence after surgery.

Authors:  P H Lange
Journal:  Urol Clin North Am       Date:  1990-11       Impact factor: 2.241

10.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Authors:  W J Catalona; D S Smith; T L Ratliff; K M Dodds; D E Coplen; J J Yuan; J A Petros; G L Andriole
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.